Diabetes Medications & Glycemic Control
A master clinical directory of antidiabetic agents used in the management of Type 1 and Type 2 Diabetes Mellitus. This guide covers the pharmacology of insulin, biguanides, SGLT2 inhibitors, and GLP-1 agonists. Reviewed by Dr. Ahmad Baker for clinical guidelines and safety.
Futavildix is a combination medication for type 2 diabetes containing Vildagliptin and Metformin. It offers a dual-action approach by enhancing insulin secretion in response to high blood sugar and reducing glucose production by the liver. Prescribed alongside diet and exercise, it is typically taken twice daily with meals to minimize gastrointestinal side effects. While generally…
Piompride is a dual-action medication for type 2 diabetes, combining Pioglitazone to enhance insulin sensitivity and Glimepiride to boost insulin production. It’s prescribed with diet and exercise when single-drug therapy is not enough. This guide covers its uses, dosage, and significant side effects, including the high risk of hypoglycemia (low blood sugar) and potential for…
Learn about Pioglumet (Pioglitazone/Metformin) for managing type 2 diabetes. This guide covers uses, dosage, side effects, and important safety warnings. Read now.
This guide provides comprehensive information on Glustacomb, a combination medication containing metformin and pioglitazone for managing type 2 diabetes. It details the drug’s dual-action mechanism for controlling blood sugar when used with diet and exercise. Key sections cover proper dosage, potential side effects, and critical safety warnings, such as the risks of heart failure and…
Lantus, with the active ingredient insulin glargine, is a long-acting basal insulin designed to provide a steady, peakless level of insulin for up to 24 hours. It serves as the foundation of insulin therapy for both Type 1 and Type 2 diabetes by controlling blood sugar between meals and overnight. For maximum effectiveness and safety,…
HuNil Mix is a premixed human insulin containing both rapid-acting and intermediate-acting components to manage blood sugar for diabetes. This dual-action formula simplifies treatment by covering mealtime spikes and providing background control with fewer daily injections. A critical safety feature is its U-40 (40 IU/ml) concentration, which requires the exclusive use of matching U-40 syringes…
Humalog Mix25 is a modern, premixed insulin analog used for managing diabetes, combining 25% ultra-rapid-acting insulin lispro with 75% intermediate-acting lispro protamine. This formulation provides fast mealtime coverage, acting within 15 minutes, while also offering longer background control, simplifying injection routines. The primary risk associated with its use is hypoglycemia, making it critical for patients…
Insulin H Mix 100 is a premixed human insulin containing a 30/70 blend of fast-acting and intermediate-acting insulin. This dual-action formula is designed to manage both post-meal blood sugar spikes and provide steady control between meals, simplifying the treatment regimen for people with diabetes. Proper use involves injecting 30 minutes before meals, rotating injection sites,…
Competact is a combination prescription drug containing Pioglitazone and Metformin, designed to treat type 2 diabetes in adults. It offers a dual-action approach by reducing the liver’s glucose production and increasing the body’s sensitivity to its own insulin. While effective for blood sugar control, patients must be aware of significant risks, including lactic acidosis and…
A guide to Empagliform (empagliflozin/metformin) for type 2 diabetes, covering its dual-action mechanism, benefits, dosage, and overall safety.